CONTINUING MEDICAL EDUCATION:
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Imedex, LLC designates this educational activity for a maximum 13.0 of AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

 

WHO SHOULD ATTEND?
This educational activity is specifically designed for medical and radiation oncologists, gastroenterologists, colorectal surgeons and other healthcare professionals (gastroenterology and oncology nurses) in active clinical practice who wish to review and update their knowledge and management of colorectal cancer.

 

OBJECTIVES:
After successful completion of this continuing medical education activity, participants should be able to:

• Comment on the latest scientific developments in the understanding of colorectal tumor biology
  
• Identify contemporary methods related to screening, surveillance and prevention of colorectal cancer patients
  
• Discuss state-of-the-art surgical and staging procedures for colon and rectal cancer
  
• Select the most appropriate adjuvant regimens for patients with colon and rectal cancer
  
• Describe a systematic continuum of care for patients with advanced disease including selecting the most appropriate first and second line chemotherapy regimens
  
• Discuss symptom management and supportive care issues in the management of colorectal cancer patients
  
• Identify promising emerging agents in the treatment of colorectal cancer
  
• Describe clinical and molecular features that guide physicians during the identification and management of patients with colorectal cancer

Timothy J. Akhurst, MD Memorial Sloan-Kettering Cancer Center New York, New York Milan J. Anadkat, MD Washington University in St. Louis St. Louis, Missouri Nancy N. Baxter, MD, PhD, FRCSC University of Toronto St. Michael’s Hospital Toronto, Ontario, Canada A. William Blackstock, Jr., MD Wake Forest University School of Medicine Winston-Salem North Carolina Steven J. Cohen, MD Fox Chase Cancer Center Philadelphia, Pennsylvania Thomas J. George, MD University of Florida Gainesville, Florida

Eugene W. Gerner, MD Arizona Cancer Center Tucson, Arizona Francis M. Giardiello, MD Johns Hopkins University Baltimore, Maryland Richard M. Goldberg, MD The University of North Carolina at Chapel Hill Chapel Hill, North Carolina Catherine Handy, PhD, RN, AOCN St. Vincent’s Comprehensive Cancer Center New York, New York Henry T. Lynch, MD Creighton University School of Medicine Omaha, Nebraska Timothy Maughan, MD University of Wales Cardiff, United Kingdom

Timothy Pawlik, MD, MPH Johns Hopkins University School of Medicine Baltimore, Maryland Karen A. Roesser, RN, MS, AOCN Thomas Johns Cancer Center Richmond, Virginia Mace L. Rothenberg, MD Vanderbilt University Nashville, Tennessee Ali A. Siddiqui, MD University of Texas Southwestern Medical Center Dallas, Texas David P. Ryan, MD Harvard Medical School Massachusetts General Hospital Boston, Massachusetts Katherine S. Virgo, PhD, MBA American Cancer Society Atlanta, Georgia

Friday, September 19, 2008

8:00 am
Welcome and introduction
Richard M. Goldberg, MD

Session I: Biology and pathogenesis
Moderator: Francis M. Giardiello, MD

8:10 am
Cell signaling in colorectal cancer
Francis M. Giardiello, MD

8:30 am
Genetics of colorectal cancer: Hereditary aspects
Henry T. Lynch, MD

8:50 am
Panel discussion

Session II: Screening and prevention
Moderator: Speaker invited

9:10 am
Optimal strategies for surveillance after initial treatment
Kathy S. Virgo, PhD

9:30 am
Applying translational research to the clinic: Concepts in colorectal cancer prevention
Eugene W. Gerner, MD

9:50 am
Coffee break

10:10 am
Will virtual colonoscopy replace optical colonoscopy for colorectal cancer screening?
Ali A. Siddigui, MD

10:30 am
Molecular markers for colorectal cancer screening and validation
Eugen W. Gerner, PhD

10:50 am
Panel discussion

11:10 am
Fellows clinical case studies and expert discussion: Determining screening recommendations based on family history
Kamal Khalid, MD
Manmeet Ahluwalia, MD

11:40 pm
Lunch break

Session IIIa: Colorectal surgery and staging
Moderator: Timothy J. Akhurst, MD

1:15 pm
PET scan vs. whole-body CT scan in the preoperative staging of colorectal cancer
Timothy J. Akhurst, MD

1:35 pm
Advances in colorectal surgery
Nancy N. Baxter, MD, PhD, FRCSC

1:55 pm
Staging of rectal cancer: MRI versus ultrasound
Ali A. Siddqui, MD

2:15 pm
Altering outcomes: Interventions for hepatic metastases
Timothy Pawlik, MD, MPH

2:35 pm
Panel discussion

2:55 pm
Coffee break

Session IIIb: Symptom management and supportive care
Moderator: Karen A. Roesser, RN, MS, AOCN

1:15 pm
Diarrhea: Identifying who's at increased risk and offering the appropriate management
Karen A. Roesser, RN, MS, AOCN

1:40 pm
Optimizing the treatment strategies for chemotherapy-induced neurotoxicity
Catherine Handy, PhD, RN, AOCN

2:05 pm
Mechanisms and management of EGFR inhibitor associated dermatologic toxicities
Milan J. Anadkat, MD

2:30 pm
Panel discussion

2:50 pm
Coffee break

Session IV: Adjuvant treatment for rectal cancer
Moderator: Speaker invited

3:15 pm
Optimizing standards in the surgical management of rectal cancer
Speaker invited

3:35 pm
Perioperative adjuvant chemotherapy for locally advanced rectal cancer
David P. Ryan, MD

3:55 pm
Adjuvant radiation therapy for rectal cancers: Evidence from randomized trials and applications to practice
A. William Blackstock, Jr., MD

4:15 pm
Panel discussion

4:35 pm
Closing remarks
Richard M. Goldberg, MD and Mace L. Rothenberg, MD

4:40 pm
Adjourn

 

Saturday September 20, 2008

8:00 am
Introduction
Mace L. Rothenberg, MD

Session V: Adjuvant treatment for locally advanced colon cancer
Moderator: Speaker invited

8:10 am
Currently available adjuvant treatment of stage II/III colon cancer
Thomas J. George, MD

8:30 am
Perspectives on the future of biologics in the adjuvant setting
Speaker invited

8:50 am
Clinical and molecular features guiding us in adjuvant therapy
Thomas J. George, MD

9:10 am
Panel discussion

9:30 am
Fellows clinical case studies and expert discussion: Adjuvant therapy for locally advanced disease
Laura Raftery, MD
Deepthi Subramanga, MD

10:00 am
Coffee break

Session VI: Metastatic colorectal cancer I
Moderator: Richard M. Goldberg, MD

10:20 am
Frontline chemotherapy for metastatic colorectal cancer: Single agents versus combinations versus sequential therapy

European perspective
Timothy Maughan, MD

American perspective
Richard M. Goldberg, MD

11:00 am
Systematic continuum of care: Second and third-line treatment for metastatic colorectal cancer
Timothy Maughan, MD

11:25 am
Predicting survival in metastatic colorectal cancer
Steven J. Cohen, MD

11:50 am
Panel discussion

12:10 pm
Lunch break

Session VII: Metastatic colorectal cancer II
Moderator: Richard M. Goldberg, MD

1:15 pm
Antiangiogenic therapy for colorectal cancer
Steven J. Cohen, MD

1:40 pm
Targeting EGFR: Implications in colorectal cancer management
David P. Ryan, MD

2:05 pm
Innovative and emerging agents for metastatic colorectal cancer
Mace L. Rothenberg, MD

2:30 pm
Fellows clinical case studies and expert discussion: Metastatic colorectal cancer
Petros Grivas, MD

3:00 pm
Panel discussion

3:20 pm
Closing remarks
Richard M. Goldberg, MD and Mace L. Rothenberg, MD

3:30 pm
Adjourn

REGISTRATION FEES:

Regular Physician . . . . . . . . . . . . . $295
If payment received by September 11, 2008

Full/Onsite Physician . . . . . . . . . . . $395
If payment received after September 11, 2008

Group discount (physicians only)*. . . -$50
*cannot be combined with any other discounts

Nurses/Residents/Students* . . . . . . . $75
*Proof of eligibility must accompany registration

To Register: You may register online by September 11, 2008 at www.imedex.com, by calling Imedex at +1 (678) 242 0906. Registration confirmations will be issued before the meeting.

To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.

Group Discounts: Each one of multiple registrants from the same institute or practice each receive a $50 discount off the published registration fees, provided all registration forms and payments are received together. Only one discount will apply per physician. Discounts are not available for Nurses/Residents/Students rate.

Payment: To pre-register, registration and payment must be received no later than September 11, 2008. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the course is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card or check. Checks should be payable to Imedex. An attendee is not registered until full payment is received.

Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, conference materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the agenda.

Cancellation: For registration fees to be refunded, written notice of cancellation must be received at Imedex no later than September 11, 2008. The amount of registration fees remitted, minus a $75 administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after September 11, 2008.

Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.

InterContinental Miami
100 Chopin Plaza
Miami, Florida 33131
Tel.: +1 (305) 577 1000
Fax: +1 (305) 577 0384
http://www.icmiamihotel.com/

The InterContinental Miami offers richly appointed accommodations and state of the art conference facilities. Discover this enchanting downtown Miami hotel, in a magical setting and enjoy the following:

• Overlooking Biscayne Bay, in the heart of Miami
  
• Minutes from South Beach, the Port of Miami, Coconut Grove, and Coral Gables
  
• Only 7.5 miles from Miami International Airport (MIA)
  
• Just 25 miles from Fort Lauderdale International Airport (FLL)
  
• Modern fitness center
  
• Three stylish restaurants and cocktail lounges

For the convenience of attendees, a limited number of rooms have been reserved until August 27, 2008 at a discounted rate of $165 single/double occupancy, plus tax, currently at 13%. This rate is not guaranteed outside the conference dates or after August 27, 2008.

To reserve your room please contact the InterContinental Miami reservations department at (866) 396 7606. To receive the group rate, callers must identify themselves as being with the 9th Annual Perspectives in Colorectal Cancer group. Reservation requests received after August 27, 2008 may not be guaranteed the group rate.

 

Chairs:
Richard M. Goldberg, MD
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Mace L. Rothenberg, MD
Vanderbilt University
Nashville, Tennessee

 

INVITATION:
Dear Colleague,

It is with great pleasure and enthusiasm that we invite you to attend the 9th Annual Perspectives in Colorectal Cancer.

We are certain you will value the unique approach of this meeting in its coverage of a broad range of topics dealing with colorectal cancer. From genetics to the management of advanced disease, from screening to surgery and supportive care, from the optimal use of standard therapies to expert perspectives on emerging agents, the full spectrum of clinical management will be addressed. Our ultimate goal is to provide you with the information needed to optimize care of your colorectal cancer patients and to direct your attention to those trends and evolutions that may affect your practice in the future.

Again this year we will be examining and discussing challenging cases submitted by clinical oncology fellows. We received many positive comments last year about the fresh approach and valuable information these presentations provide to attendees. We encourage fellows to submit their cases for consideration by the July 11th deadline.

We are sure you will find this meeting to be informative and enjoyable. We look forward to welcoming you in Miami again this September!

Sincerely,
Richard M. Goldberg, MD
Mace L. Rothenberg, MD

 

Conference Location and Registration:
InterContinental Miami
100 Chopin Plaza
Miami, Florida 33131
Tel.: +1 (305) 577 1000
Fax: +1 (305) 577 0384

 

The Registration and Information Desk will be staffed:
Friday, September 19, 2008 . . . . . . 7:00 am – 4:00 pm
Saturday, September 20, 2008 . . . . .7:00 am – 4:30 pm

 

Travel/Education Grants
Applications are now available for a limited number of travel/education grants for fellows or residents to the 9th Annual Perspectives in Colorectal Cancer. The grant will provide each fellow or resident with complimentary conference registration, up to 2 nights (September 18-19, 2008) single or double occupancy at the Intercontinental Miami and round-trip travel to Miami, Florida (up to $400).

Applicants are required to submit at least one clinical case for possible presentation at the meeting in one or more of the following areas:

1) determining screening recommendations based on family history

2) adjuvant therapy for locally advanced colon cancer

3) metastatic colorectal cancer

Applications are available online at www.imedex.com/A035.01application.pdf or may be requested by email to meetings@imedex.com. Grant applications must be received at Imedex by July 11, 2008. Notification of acceptance will be sent by July 25, 2008.

 

Discounted Airfare
Contact conference travel agent, Williamsburg Travel, for assistance with your travel needs. Williamsburg Travel can also accommodate pre- and post-conference extensions.
Tel.: +1 (888) 232 9394 or
+1 (770) 261 8613
Email: judit@willtrav.com

 

Important Dates
Discounted Registration Deadline: July 24, 2008
Regular Registration Deadline: September 11, 2008
Presentation Dates: September 19-20, 2008

 

ORGANIZER
Imedex
4325 Alexander Drive
Alpharetta, GA 30022-3740 USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com

 

Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.

In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.

©2008 Imedex^®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.

CORPORATE SUPPORT:
The following companies have provided an unrestricted educational grant in support of this conference:

 

Gold Bronze Corporate Exhibitor

 

Several options are available to companies interested in supporting this congress. For more information, please contact Imedex at +1 (770) 751 7332 or by email at cme@imedex.com.